Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...

The UC Santa Cruz RNA Center hosted a premiere screening of “Cracking the Code: Phil Sharp and the Biotech Revolution” at the ...

People with advanced skin and lung cancers who received mRNA Covid-19 vaccines within 100 days of starting immunotherapy ...

Scientists from CNRS have developed new stable and effective messenger RNA (mRNA) sequences that enable cells to produce therapeutic proteins themselves, capable of inducing antibody ...

Innorna Co., a Chinese developer of messenger RNA drugs backed by buyout firm CDH Investments, is planning an initial public ...

Retsef Levi may not be a household name, but he is already impacting how every household in the United States will access ...

PLANO, TX / ACCESS Newswire / October 21, 2025 / BGSF, Inc. ( NYSE:BGSF ), a growing provider of workforce solutions for the specialized property management industry, today announces that ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

Cidara’s lead candidate, CD388, is a long-acting antiviral prophylactic designed for universal prevention of seasonal and ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

Further validating the results, University of Florida researchers found that tying cancer immunotherapies with COVID-targeted ...